|
A.A. Podoynicin, E.A. Mamedov, N.А. Amosov, S.V. Garmash, D.A. Kuznecova, E.V. Shpot, G.A. Mashin, P.Sh. Maltsagova
Clinical case: bladder necrosis after prostate embolization in a patient with prostatic hyperplasia
|
№1 / 2023
|
|
I.A. Shaderkin, G.S. Lebedev, V.A. Shaderkina, D.M. Monakov,
L.G. Spivak, Z.K. Gadzhieva, M.A. Gazimiev
Outpatient urodynamic monitoring in patients with BPH: world and russian experience
|
№6 / 2021
|
|
V.A. Dudarev, V.Yu Startsev
Factors predicting the development of urinary tract disorders in prostatic hyperplasia in elderly men
|
№6 / 2018
|
|
L.M. Rapoport, N.I. Sorokin, R.B. Sukhanov, A.M. Dymov, D.V. Enikeev, D.S. Davydov, S.P. Danilov
En bloc holmium laser enucleation of the prostate (HOLEP EN BLOC): our experience
|
№3 / 2018
|
|
Yu.G. Alyaev, A.M. Pshikhachev, A.N. Perekalina
The risk of bladder cancer in patients with prostatic hyperplasia and strategies to manage this combination
|
№5 / 2016
|
|
L.G. Spivak, K.L. Lokshin, A.Z. Vinarov
Review of Clinical Studies on Combination Therapy of 5α-Reductase Inhibitors and α1-Blockers in Patients with Benign Prostatic Hyperplasia
|
№4 / 2015
|
Русский
